CorMedix Historical Financial Ratios

CRMD Stock

USD 8.57 0.30 3.38%

CorMedix is presently reporting on over 107 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0179, PTB Ratio of 2.87 or Days Sales Outstanding of 162 will help investors to properly organize and evaluate CorMedix financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CorMedix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.

About CorMedix Financial Ratios Analysis

CorMedixFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate CorMedix investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on CorMedix financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across CorMedix history.

CorMedix Financial Ratios Chart

At present, CorMedix's Days Sales Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 1.45, whereas Free Cash Flow Yield is forecasted to decline to (0.21).

Dividend Yield Days Sales Outstanding Average Payables Roic Days Of Inventory On Hand Short Term Coverage Ratios

Add Fundamental

Dividend Yield

Dividend Yield is CorMedix dividend as a percentage of CorMedix stock price. CorMedix dividend yield is a measure of CorMedix stock productivity, which can be interpreted as interest rate earned on an CorMedix investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Roic

Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.

Most ratios from CorMedix's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into CorMedix current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CorMedix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.At present, CorMedix's Days Sales Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 1.45, whereas Free Cash Flow Yield is forecasted to decline to (0.21).

	2023	2024 (projected)
Dividend Yield	0.0202	0.0179
Price To Sales Ratio	3.0K	1.6K

Dividend Yield Price To Sales Ratio

CorMedix fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding
Price To Sales Ratio		0.1	-0.55	0.7	-0.66	-0.31	-0.09	-0.54	-0.02	-0.55	1.0	-0.09	0.53	-0.11	-0.23	-0.2	0.39	-0.51	0.97	-0.47	0.23	0.48	-0.05	0.13	0.22	-0.04
Dividend Yield	0.1		-0.2	0.11	-0.11	-0.12	-0.3	0.16	0.03	-0.2	0.11	-0.3	0.14	0.13	-0.33	-0.68	0.25	-0.53	0.13	-0.15	-0.05	-0.15	-0.79	-0.01	-0.05	0.07
Ptb Ratio	-0.55	-0.2		-0.32	0.32	-0.1	-0.23	-0.04	-0.22	1.0	-0.55	-0.23	-0.79	-0.05	-0.31	0.19	-0.02	0.32	-0.56	0.31	-0.01	-0.27	0.2	0.1	-0.01	-0.01
Days Sales Outstanding	0.7	0.11	-0.32		-0.19	-0.24	-0.28	-0.59	-0.08	-0.32	0.71	-0.28	0.39	-0.12	-0.46	-0.28	0.34	-0.49	0.7	0.19	0.3	0.39	-0.15	0.17	0.29	-0.17
Book Value Per Share	-0.66	-0.11	0.32	-0.19		0.0	-0.01	0.45	0.07	0.32	-0.66	-0.01	-0.58	0.07	0.29	0.17	-0.71	0.4	-0.65	0.76	0.11	-0.27	0.11	-0.11	0.12	0.09
Free Cash Flow Yield	-0.31	-0.12	-0.1	-0.24	0.0		0.66	0.5	0.16	-0.1	-0.31	0.66	0.32	0.11	0.26	0.08	0.14	0.3	-0.31	0.17	-0.7	0.0	0.12	-0.19	-0.7	0.12
Operating Cash Flow Per Share	-0.09	-0.3	-0.23	-0.28	-0.01	0.66		0.57	0.34	-0.23	-0.11	1.0	0.17	0.26	0.71	0.32	-0.19	0.48	-0.09	-0.17	-0.71	0.51	0.31	-0.4	-0.7	0.29
Average Payables	-0.54	0.16	-0.04	-0.59	0.45	0.5	0.57		0.42	-0.04	-0.56	0.56	-0.19	0.33	0.58	0.2	-0.57	0.51	-0.52	0.11	-0.39	-0.06	0.05	-0.45	-0.37	0.38
Capex To Depreciation	-0.02	0.03	-0.22	-0.08	0.07	0.16	0.34	0.42		-0.22	-0.03	0.33	0.07	0.92	0.28	-0.1	-0.3	0.41	0.17	-0.06	-0.08	0.15	0.01	-0.97	-0.04	-0.04
Pb Ratio	-0.55	-0.2	1.0	-0.32	0.32	-0.1	-0.23	-0.04	-0.22		-0.55	-0.23	-0.79	-0.05	-0.31	0.19	-0.02	0.32	-0.56	0.31	-0.01	-0.27	0.2	0.1	-0.01	-0.01
Ev To Sales	1.0	0.11	-0.55	0.71	-0.66	-0.31	-0.11	-0.56	-0.03	-0.55		-0.11	0.54	-0.11	-0.25	-0.22	0.4	-0.54	0.97	-0.47	0.23	0.47	-0.08	0.14	0.22	-0.07
Free Cash Flow Per Share	-0.09	-0.3	-0.23	-0.28	-0.01	0.66	1.0	0.56	0.33	-0.23	-0.11		0.17	0.25	0.71	0.32	-0.18	0.47	-0.09	-0.17	-0.71	0.51	0.31	-0.39	-0.7	0.29
Roic	0.53	0.14	-0.79	0.39	-0.58	0.32	0.17	-0.19	0.07	-0.79	0.54	0.17		-0.03	-0.03	-0.2	0.51	-0.35	0.53	-0.32	-0.14	0.26	-0.14	0.02	-0.14	-0.07
Inventory Turnover	-0.11	0.13	-0.05	-0.12	0.07	0.11	0.26	0.33	0.92	-0.05	-0.11	0.25	-0.03		0.25	-0.26	-0.12	0.38	0.11	0.01	-0.22	0.09	-0.14	-0.97	-0.18	-0.09
Net Income Per Share	-0.23	-0.33	-0.31	-0.46	0.29	0.26	0.71	0.58	0.28	-0.31	-0.25	0.71	-0.03	0.25		0.41	-0.55	0.55	-0.23	0.0	-0.38	0.22	0.34	-0.36	-0.37	0.3
Days Of Inventory On Hand	-0.2	-0.68	0.19	-0.28	0.17	0.08	0.32	0.2	-0.1	0.19	-0.22	0.32	-0.2	-0.26	0.41		-0.42	0.72	-0.29	0.07	0.09	0.16	0.67	0.08	0.08	0.58
Payables Turnover	0.39	0.25	-0.02	0.34	-0.71	0.14	-0.19	-0.57	-0.3	-0.02	0.4	-0.18	0.51	-0.12	-0.55	-0.42		-0.52	0.38	-0.25	-0.31	0.14	-0.25	0.27	-0.32	-0.25
Average Inventory	-0.51	-0.53	0.32	-0.49	0.4	0.3	0.48	0.51	0.41	0.32	-0.54	0.47	-0.35	0.38	0.55	0.72	-0.52		-0.46	0.24	-0.14	-0.05	0.52	-0.51	-0.12	0.47
Capex To Revenue	0.97	0.13	-0.56	0.7	-0.65	-0.31	-0.09	-0.52	0.17	-0.56	0.97	-0.09	0.53	0.11	-0.23	-0.29	0.38	-0.46		-0.46	0.22	0.47	-0.12	-0.07	0.22	-0.11
Cash Per Share	-0.47	-0.15	0.31	0.19	0.76	0.17	-0.17	0.11	-0.06	0.31	-0.47	-0.17	-0.32	0.01	0.0	0.07	-0.25	0.24	-0.46		0.02	-0.23	0.06	0.01	0.03	-0.02
Pocfratio	0.23	-0.05	-0.01	0.3	0.11	-0.7	-0.71	-0.39	-0.08	-0.01	0.23	-0.71	-0.14	-0.22	-0.38	0.09	-0.31	-0.14	0.22	0.02		-0.36	0.06	0.21	1.0	-0.11
Interest Coverage	0.48	-0.15	-0.27	0.39	-0.27	0.0	0.51	-0.06	0.15	-0.27	0.47	0.51	0.26	0.09	0.22	0.16	0.14	-0.05	0.47	-0.23	-0.36		0.16	-0.16	-0.36	0.13
Payout Ratio	-0.05	-0.79	0.2	-0.15	0.11	0.12	0.31	0.05	0.01	0.2	-0.08	0.31	-0.14	-0.14	0.34	0.67	-0.25	0.52	-0.12	0.06	0.06	0.16		0.01	0.06	-0.07
Capex To Operating Cash Flow	0.13	-0.01	0.1	0.17	-0.11	-0.19	-0.4	-0.45	-0.97	0.1	0.14	-0.39	0.02	-0.97	-0.36	0.08	0.27	-0.51	-0.07	0.01	0.21	-0.16	0.01		0.17	-0.01
Pfcf Ratio	0.22	-0.05	-0.01	0.29	0.12	-0.7	-0.7	-0.37	-0.04	-0.01	0.22	-0.7	-0.14	-0.18	-0.37	0.08	-0.32	-0.12	0.22	0.03	1.0	-0.36	0.06	0.17		-0.11
Days Payables Outstanding	-0.04	0.07	-0.01	-0.17	0.09	0.12	0.29	0.38	-0.04	-0.01	-0.07	0.29	-0.07	-0.09	0.3	0.58	-0.25	0.47	-0.11	-0.02	-0.11	0.13	-0.07	-0.01	-0.11

Click cells to compare fundamentals

CorMedix Account Relationship Matchups

CorMedix fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	620.71	887.07	896.33	2.6K	3.0K	1.6K
Ptb Ratio	(0.9)	(0.98)	(0.7)	(0.62)	2.73	2.87
Days Sales Outstanding	9.26	0.0451	5.12	86.73	99.74	161.52
Book Value Per Share	0.98	1.55	1.67	1.37	1.38	1.45
Operating Cash Flow Per Share	(0.62)	(0.77)	(0.56)	(0.61)	(0.75)	(0.79)
Stock Based Compensation To Revenue	8.61	10.45	26.41	62.22	71.55	90.23
Capex To Depreciation	0.5	0.88	23.03	2.59	4.63	2.82
Pb Ratio	(0.9)	(0.98)	(0.7)	(0.62)	2.73	2.87
Ev To Sales	562.39	715.42	620.7	1.9K	2.2K	1.3K
Free Cash Flow Per Share	(0.62)	(0.77)	(0.6)	(0.61)	(0.76)	(0.8)
Roic	0.16	0.0822	0.1	0.11	(0.7)	(0.66)
Inventory Turnover	1.1	1.43	49.51	0.0976	0.0878	0.0834
Net Income Per Share	(0.68)	(0.77)	(0.75)	(0.74)	(0.91)	(0.96)
Days Of Inventory On Hand	331.0	255.81	7.37	3.7K	3.4K	3.5K
Payables Turnover	0.36	0.18	0.0674	0.001696	0.048	0.0456
Research And Ddevelopement To Revenue	39.02	55.92	68.78	163.28	187.77	128.18
Cash Per Share	1.18	1.63	1.75	1.47	1.49	2.39
Pocfratio	(11.68)	(9.66)	(8.09)	(6.95)	(4.98)	(5.23)
Interest Coverage	(26.68)	(819.26)	(1.8K)	(1.2K)	(1.3K)	(1.4K)
Capex To Operating Cash Flow	(0.00243)	(0.005127)	(0.0674)	(0.009006)	(0.008521)	(0.008947)
Pfcf Ratio	(11.65)	(9.61)	(7.58)	(6.89)	(4.94)	(5.19)
Days Payables Outstanding	1.0K	2.0K	5.4K	215.3K	7.6K	7.2K
Income Quality	0.92	1.0	0.75	0.82	0.83	0.55
Roe	0.15	0.0841	0.1	0.11	(0.66)	(0.63)
Ev To Operating Cash Flow	(10.58)	(7.79)	(5.6)	(5.21)	(3.86)	(4.06)
Pe Ratio	(10.7)	(9.63)	(6.07)	(5.7)	(4.13)	(4.34)
Return On Tangible Assets	(1.43)	(0.56)	(0.45)	(0.41)	(0.48)	(0.59)
Ev To Free Cash Flow	(10.56)	(7.75)	(5.25)	(5.16)	(3.83)	(4.02)
Earnings Yield	(0.0935)	(0.1)	(0.16)	(0.18)	(0.24)	(0.25)
Net Debt To E B I T D A	0.8	1.52	1.79	1.42	0.88	0.92
Current Ratio	5.04	11.58	12.44	9.44	6.97	4.06
Tangible Book Value Per Share	0.98	1.55	1.67	1.37	1.38	1.45
Receivables Turnover	39.42	8.1K	71.26	4.21	3.79	3.6
Graham Number	11.13	11.49	10.5	10.69	5.31	5.05
Shareholders Equity Per Share	(8.09)	(7.61)	(6.53)	(6.86)	1.38	1.45

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether CorMedix is a strong investment it is important to analyze CorMedix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CorMedix's future performance. For an informed investment choice regarding CorMedix Stock, refer to the following important reports:

How To Invest In CorMedix

Details

Is CorMedix Stock a good investment?

Details

What is CorMedix's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.

You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CorMedix. If investors know CorMedix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CorMedix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.80)

Revenue Per Share

0.212

Quarterly Revenue Growth

(0.47)

Return On Assets

(0.38)

Return On Equity

(0.65)

The market value of CorMedix is measured differently than its book value, which is the value of CorMedix that is recorded on the company's balance sheet. Investors also form their own opinion of CorMedix's value that differs from its market value or its book value, called intrinsic value, which is CorMedix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CorMedix's market value can be influenced by many factors that don't directly affect CorMedix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CorMedix's value and its price as these two are different measures arrived at by different means. Investors typically determine if CorMedix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CorMedix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity	Operating Cycle
Cash Conversion Cycle

CorMedix Historical Financial Ratios

About CorMedix Financial Ratios Analysis

CorMedix Financial Ratios Chart

Dividend Yield

Average Payables

Roic

CorMedix fundamentals Correlations

CorMedix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CorMedix fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pfcf Ratio	+ 1.0	Pocfratio
Capex To Revenue	+ 0.97	Price To Sales Ratio
Capex To Revenue	+ 0.97	Ev To Sales

Capex To Operating Cash Flow	- 0.97	Inventory Turnover
Capex To Operating Cash Flow	- 0.97	Capex To Depreciation
Roic	- 0.79	Pb Ratio
Roic	- 0.79	Ptb Ratio
Payout Ratio	- 0.79	Dividend Yield
Pocfratio	- 0.71	Free Cash Flow Per Share